课题基金 / 基金详情

Direct oral anticoagulants and the risk of colorectal and pancreatic cancers: a population-based cohort study.

Direct oral anticoagulants and the risk of colorectal and pancreatic cancers: a population-based cohort study.
直接口服抗凝剂与结直肠癌和胰腺癌的风险：一项基于人群的队列研究。
批准号：
474475
负责人：
Damba Joseph Junior
金额：
$10.93万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=474475&lang=en
关键词：
Anticoagulants Cohort Study Colorectal Cancer Direct Oral Anticoagulants Pancreatic Cancer Population-Based Vitamins K Antagonists

项目摘要

项目成果

Damba Joseph Junior的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Supervisor: Christel Renoux, McGill University Colorectal (CRC) and pancreatic (PC) cancers are both deadly cancers, ranking in the top three of the leading causes of cancer death in Canada, with significant healthcare costs. Smoking, alcohol abuse, and
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Direct oral anticoagulants and the risk of colorectal and pancreatic cancers: a population-based cohort study
海外基金